VS
When evaluating costs, PRP features a management fee (MER) of 0.55%, compared to 0.18% for HGRW. Performance-wise, PRP has returned 4.33% year-to-date with +$0 M in net flows, whereas HGRW is at 5.37% with +$3 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
PRP
HGRW
| AuM | $1.01 M | $36.60 M |
| Management Fees | 0.55% | 0.18% |
| Exp. ratio | 0.86% | 0.20% |
| Tracking Difference | - | - |
Historical performance and flows
As of November 19, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | PRP | +0.88% | -0.79% | +4.33% | +4.91% | +19.94% |
HGRW | -6.24% | -5.94% | +5.37% | +8.13% | +48.59% | |
| Flows | PRP | +$0 M | +$0 M | +$0 M | +$0 M | -$0 M |
HGRW | +$2 M | +$2 M | +$3 M | +$3 M | +$28 M |
PRP vs HGRW exposure
Countries
PRP
USA
51.28%
Other
25.64%
Canada
20.16%
HGRW
Other
100.00%
Sectors
PRP
Other
25.64%
Finance
18.49%
Technology
7.98%
Energy
7.13%
Other
40.76%
HGRW
Other
100.00%
As of November 19, 2026
Top 10 Holdings
PRP
CA74642H1010
23.81%
US4642885135
17.96%
US4642874329
4.26%
The Toronto-Dominion Bank
1.55%
The Bank of Nova Scotia
1.51%
Royal Bank of Canada
1.37%
Canadian Imperial Bank of Commerce
1.31%
CA74643B1031
1.29%
Manulife Financial Corp.
1.21%
AbbVie, Inc.
1.05%
HGRW
CA37962A1057
28.46%
CA37962B1031
19.77%
CA37961W1086
16.15%
CA37967D1042
9.44%
CA37961X1069
6.59%
CA37962C1014
6.24%
CA37967A1003
5.70%
CA37965A1021
3.81%
CA37893H2037
1.89%
CA37966Y1097
1.89%
Diversification
PRP
Total weight of top 10 holdings out of 1,541 total
55.32%
HGRW
Total weight of top 10 holdings out of 11 total
99.93%
Characteristics
Compare
PRP
HGRW
| Provider | Purpose Investments | Global X |
| Management | Actively managed | Actively managed |
| Benchmark | - | - |
| Replication Method | - | - |
| Asset Class | Equity, Fixed Income | Equity, Fixed Income |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 3.56% | 2.10% |
| Meets ESG criteria | No | No |
| Inception Date | October 26, 2016 | October 10, 2023 |
Frequently asked questions about PRP and HGRW
Which ETF has performed better year to date: PRP or HGRW?
As of November 19, 2026, PRP has returned 4.33% year to date, while HGRW has returned 5.37%. HGRW is ahead on YTD performance.
Which ETF is larger by assets under management: PRP or HGRW?
As of November 19, 2026, PRP manages $1.01 M in assets, while HGRW manages $36.60 M. HGRW is the larger fund by AUM.
How are PRP and HGRW managed?
PRP is actively managed by Purpose Investments. It does not track an index. HGRW is actively managed by Global X. It does not track an index.
Which ETF is attracting more investor flows: PRP or HGRW?
Year to date, PRP has seen +$0.00 M in net flows, compared with +$3.40 M for HGRW. HGRW has attracted more net investor money so far.
How do the fees of PRP and HGRW compare?
PRP has an expense ratio of 0.86%, while HGRW has an expense ratio of 0.20%.
Which ETF is more diversified: PRP or HGRW?
PRP holds 144 securities, while HGRW holds 1. On holdings count, PRP is the more diversified portfolio.
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

